Back Stocks profile

Stock analysis tool for investors

Anuh Pharma Ltd.

NSE: ANUHPHR | BSE:506260

₹235.60 5.80 (2.52%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

228.30

Today’s High

239.00

52W low

97.10

52W High

265.00

Open Price

230.00

Prev. Close

221.6500

Volume

102846.00

Value

24230517.60

Fundamentals

Market Cap

1180.60

Price to Earnings

19.70

Price to Book Value

4.10

Dividend Yield

0.80

PE to Growth

0.30

Op Revenue TTM

647.00

Net Profit TTM

60.06

Cash From Operating Activity

12.93

Return on Equity %

20.62

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

71.4

Week

72.8

Month

72.6

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

234.28

PIVOT

First Resistance

240.27

Second Resistance

244.93

Third Resistance

250.92

First Support

229.62

Second Support

223.63

Third Support

218.97

Relative Strength Index

56.61

Money Flow Index

51.03

MACD

-0.29

MACD Signal

-1.28

Average True Range

9.42

Average Directional Index

9.72

Rate of Change (21)

7.12

Rate of Change (125)

40.2

Commodity Channel Index

97.3

Williams %R

-38.9

BETA

1 Month

0.73

3 Month

0.42

1 Year

0.64

3 Year

0.33

PRICE CHANGE ANALYSIS

6.1%

1 Week

Low

High

222.55

238.95

6.29%

1 Month

Low

High

221

244.9

-5.78%

3 Months

Low

High

202.05

261

33.33%

6 Months

Low

High

155.1

265

125.24%

1 Year

Low

High

97.1

265

Bigul
24 Jun 2024

ANUH PHARMA LTD. - 506260 - Closure of Trading Window

Intimation regarding the Closure of Trading Window for dealing in Securities of the Company shall remain closed from Monday, July 01, 2024 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the Quarter ended June 30, 2024.
Bigul
31 May 2024

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Acquisition

Disclosure for investment in Huoban Energy 5 Private Limited a Special Purpose Vehicle, for Solar Projects under group captive model through open access has been signed by the parties to the Agreement on 31st May, 2024.
Bigul
27 May 2024

ANUH PHARMA LTD. - 506260 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2024.
Bigul
18 May 2024

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of the Audited Financial Results for the Quarter and Year ended 31st March, 2024, published in the Financial Express in English Language and Mumbai Lakshadeep in Marathi Language on 18th May, 2024.
Bigul
17 May 2024

ANUH PHARMA LTD. - 506260 - Results-Financial Year Ended 31St March, 2024

Results for Financial year ended 31st March, 2024
Bigul
17 May 2024

ANUH PHARMA LTD. - 506260 - Board Meeting Outcome for Board Meeting Outcome Board Meeting Held On 17/05/2024

TO consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2024, recommendation of Dividend for the Financial Year, 2023-24 and Fixation the date of AGM pf the Company.
Bigul
09 May 2024

ANUH PHARMA LTD. - 506260 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Financial Year Ended 31St March, 2024 And Recommendation Of Final Dividend, If Any, For The Financial Year 2023-24.

ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve Audited Financial Results for the Quarter and Financial Year ended 31st March, 2024 and recommendation of Final Dividend, if any, for the Financial Year 2023-24.
Bigul
29 Apr 2024

ANUH PHARMA LTD. - 506260 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyANUH PHARMA LTD. 2CIN NO.L24230MH1960PLC011586 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Manan Vadhan Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Darshan Rampariya Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Bigul
24 Apr 2024

ANUH PHARMA LTD. - 506260 - Compliances-Compliance Certificate For The Financial Ended 31St March, 2024

Compliance Certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 being received from RTA for the Financial Year ended 31st March, 2024.
See all News

FAQs

The latest market price of Anuh Pharma Ltd. on NSE was Rs. 235.60 as of today.

The opening share price of Anuh Pharma Ltd. was Rs. 230.00 as of today.

The 52-week high share price of Anuh Pharma Ltd. was Rs. 265.00.

The 52 week low share price of Anuh Pharma Ltd. was Rs. 97.10.

Please find Corporate actions section for more details.

The PE ratio of Anuh Pharma Ltd. is 0.30. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Anuh Pharma Ltd. was on 2023-08-11 for Rs. 2 per share. According to today’s share price, the dividend yield of Anuh Pharma Ltd. stands at 0.80. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Anuh Pharma Ltd. was as of 2020-09-18. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Anuh Pharma Ltd. was as of 2006-07-31. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Anuh Pharma Ltd..

Close

Let's Open Free Demat Account